India’s MedPlus Health Q3 profit triples on strong OTC drug demand
India’s MedPlus Health Services reported a surge in third-quarter profit on Friday, driven by store expansions and strong demand for over-the-counter medicines.
Related Articles
Why Osaka has banned smoking, vaping in public?
Ahead of World Expo 2025, Osaka, the host and one of the biggest Japanese cities has completely banned smoking and vaping in all public places.…
Study Highlights Findings on Treatments for HS During Pregnancy, Lactation
This literature review explored the topic of hidradenitis suppurativa management during pregnancy and lactation, highlighting data available on this topic.
Nvidia’s new ‘Studio Voice’ AI feature makes your crappy mic sound pro
Nvidia is leaning even heavier into AI, this time with webcam enhancements that are pretty impressive.
HCSC tightens asthma infusion coverage, providers slam decision
Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma infusion treatment, drawing concerns from providers. | Health…
Journal of Cardiac Failure
The Journal of Cardiac Failure (JCF) publishes the highest quality science in the field of heart failure with a focus on diversity, equity, and inclusion, mentorship, multidisciplinary…
A brief history of the ‘physicist’
Nature Reviews Physics – Although the practice of doing physics has a long history, the term ‘physicist’ is less than 200 years old. Historian Iwan…
Study Highlights Findings on Treatments for HS During Pregnancy, Lactation
This literature review explored the topic of hidradenitis suppurativa management during pregnancy and lactation, highlighting data available on this topic.
How Should Health Care and Public Health Respond to the New US Administration?
This Viewpoint discusses scientific, medical, and public health actions, including withdrawing from the World Health Organization, taken so far during the first week of the…
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
The FDA approved Journavx (suzetrigine) 50 mg oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.
National Science Foundation suspends salary payments, leaving researchers unable to pay their bills
An NSF online payment system remained down after the federal funding freeze was lifted, leaving early-career scientists scrambling to pay bills
